
GE Healthcare launched Discovery NM/CT 670
GE Healthcare announced the European launch of Discovery NM/CT 670, a hybrid imaging platform designed to improve workflow, dose management, and overall image quality.

GE Healthcare announced the European launch of Discovery NM/CT 670, a hybrid imaging platform designed to improve workflow, dose management, and overall image quality.
Chirurgen an der Charité haben in kolorektalem Tumorgewebe eine spezifische Anhäufung von Protoporphyrin-IX (PpIX), einem rot-fluoreszierenden Vorläufermolekül des Häms beobachtet. Wir konnten zeigen, dass diese Anhäufung von PpIX darauf zurückzuführen ist, dass das Enzym, das PpIX normalerweise in Häm überführt, die sogenannte…
Advances in cancer prevention and treatment reported at this week´s premier European congress for specialists in gynaecological cancers show that care is being more effectively tailored to the needs of individual women, so that survival can be improved without the cost of added complications and reduced quality of life.

Siemens Healthcare reported at the annual meeting of the European Association of Nuclear medicine (EANM) in Barcelona, Spain, that leading hospitals in England, France, Germany and Monaco have shown strong interest and adoption of the Biograph mCT, the worlds first molecular CT, to fuel advanced diagnostic capabilities and to drive greater workflow efficiencies.

The University of Pennsylvania Health System, one of the largest health systems in the US, has awarded a $135 million contract for Integrated Service Management to Siemens Healthcare. Over the next seven years, Siemens will be servicing and ensuring around-the-clock availability of diagnostic systems and bio-medical devices from diverse manufacturers in the customer´s various hospitals.

In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers.

The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only congress in Europe that covers the entire spectrum of cancer from basic science and translational research, to prevention, treatment, nursing and supportive care for all types of tumours.
A new initiative designed to inform and educate policymakers at national, European, and global level about the needs of the oncology community was launched at Europe's largest cancer congress, ECCO 15 — ESMO 34, in Berlin. The European Academy of Cancer Sciences will help to keep the interests of cancer patients at the forefront of the policy agenda, and avoid policy decisions that had a…
Removal of the primary breast tumour in women whose cancer has already spread to other parts of the body can have a significant effect on their survival, Dutch researchers have found. Their research meant that women who were diagnosed at a late stage of the disease could expect to survive longer. They discovered that those patients who had received surgery survived for considerably longer than…

Colorectal cancer (CRC) jointly describes cancers of the colon and rectum. Worldwide, CRCs are among the most common cancers. In Europe and the USA the occurrence of CRCs are considerably higher than in Africa and Asia.

With its new diagnostic reporting software for breast imaging in magnetic resonance imaging (MRI), Siemens Healthcare provides radiologists with new opportunities in Women's Health. The syngo BreVis diagnostic reporting software shows all of a patient's examination results in a single view - for example ultrasound or radiography images next to the images from magnetic resonance imaging -…

Today, transcatheter aortic valve implantation (TAVI) represents an effective therapeutic alternative to conventional aortic valve replacement for patients who are at high risk or with contraindications to surgery, and the combination of the transfemoral and transapical approaches further increases the number of patients who can be treated.

Western societies are struggling to pay for their ever increasing medical budgets. In the US up to 393 billion US-$ were spent in 2005 for cardiovascular diseases alone. Based on epidemiologic studies in primary prevention it is reasonable to estimate that 30% of coronary heart disease and stroke could be prevented by 2.5 hours of brisk walking per week.
After two years of intensive work the results from the German pilot phase of the EuroCMR Register are due to be published in the forthcoming issue of the Journal of the American College of Cardiology*, and also presented and discussed in detail at this year's ECR in Barcelona.

Surviving a heart attack depends upon where you live in Europe. For cardiologists that is unacceptable. A majority of European countries can deliver life-saving primary percutaneous coronary interventions (P-PCI), yet too often these centres are closed over weekends or after working hours - when 50% of all myocardial infarctions occur.

Training healthcare personnel is not cheap; losing these human resources to other countries can prove even more costly. Where and why are nurses on the move?

The DR200M, a fully-integrated mobile digital radiography system developed by Landwind Medical (www.landwindmedical.com), is set to impress with its ergonomic design for easy-to-handle mobility, positioning at patient's bedsides and most of all speed and quality of imaging.

Since its foundation by Michael Friebe PhD in 2003, and on the basis of 10 years of business activity in radiology, Tomovation has become an established provider of high-end services for tomography applications, such as MRI, CT, and PET-CT.
Researchers around the globe are studying whether a genomic test, developed with micro-array technology, is superior to traditional methods in assessing aggressive breast cancer, and therefore could spare a considerable percentage of women from the onslaught of chemotherapy The Breast International Group (BIG) in Brussels, Belgium, manages TRANSBIG, an international network created to avoid…
3D Net Perfusion, new software developed by The Institute of Cancer Research (ICR) working with Biotronics3D, aims to improve the accuracy of MRI scan analysis and treatment efficacy by extracting data from tumour images and transforming it into usable information. In addition, the analytical tool provides a method to visualise and measure blood supply to cancers - a crucial factor in tumour…
Founded and managed by Prof Peter Schlag, the Charité Comprehensive Cancer Centre (CCCC) co-ordinates cancer diagnostics and therapies across all medical disciplines. Interdisciplinary tumour boards decide on therapies/strategies; cooperation is close with general practitioners, regional hospitals and clinics.

During a gathering of clinicians, scientists and economists at this year's Medical Technology Congress (Treffpunkt für Medizintechnik) held in Berlin's Charité Hospital, all 17 lectures focused on cancer treatments. Bettina Döbereiner reports
By David Loshak

This year's AACC, held in conjunction with the Canadian Society for Clinical Chemists, and the Annual Meeting of the American Society for Clinical Laboratory Science, featured around 200 educational sessions and drew in over 18,000 delegates and exhibitors from almost 100 countries.

Emphasising the crucial partnership of radiologists and urologists in the treatment of prostate cancer, Professor Arnulf Stenzl, Medical Director of Urology at the Tübingen University Hospital, explained that, throughout the phases of prostate cancer diagnosis and therapy - from primary diagnosis onward - imaging is indispensable.